ARCHIVES

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Wyngaarden List, Reportedly Six-Seven Names For NCI Director, Goes to White House This Week

November 11, 1988

Varmus, Duke Ask IOM To Investigate Potti’s Scientific Work, Clinical Trials

July 30, 2010

AACI Developing Suggestions Or New Cancer Control Grant Guidelines

July 20, 1979

Government Offers Two Approval Standards For Assays: CLIA, FDA

January 30, 2009

Cancer Meetings For May, June, Future

April 27, 1990

Harold Amos Receives Drew Medical Prize

October 27, 1989